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Increasing resistance of pathogenic bacteria against antibiotics is a severe problem in health care. Natural antimicrobial peptides and
derivatives thereof have emerged as promising candidates for ‘‘new antibiotics’’. In contrast to classical antibiotics, these peptides act by
direct physical destabilization of the target cell membrane. Nevertheless, they exhibit a high specificity for bacteria over mammalian cells.
However, the precise mechanism of action and the molecular basis for membrane selectivity are still a matter of debate. We have designed a
new peptide antibiotic (NK-2) with enhanced antimicrobial activity based on an effector protein of mammalian immune cells (NK-lysin).
Here we describe the interaction of this a-helical synthetic peptide with membrane mimetic systems, designed to mimic the lipid
compositions of mammalian and bacterial cytoplasmic membranes. Utilizing fluorescence and biosensor assays, we could show that on one
hand, NK-2 strongly interacts with negatively charged membranes; on the other hand, NK-2 is able to discriminate, without the necessity of
negative charges, between the zwitterionic phospholipids phosphatidylethanolamine (PE) and phosphatidylcholine (PC), the major
constituents of the outer leaflet of the cytoplasmic membranes of bacteria and mammalian cells, respectively.D 2003 Elsevier Science B.V. All rights reserved.Keywords: Antibacterial peptide; Peptide antibiotic; Model membrane; NK-lysin; Melittin1. Introduction
Natural antimicrobial peptides are part of the innate
immunity of a wide range of species ranging from insects
over amphibia to mammalia, including humans. They pro-
vide a first line of defense against infections with bacteria,
fungi, parasites and enveloped viruses, and some peptides are
even effective against tumor cells (for reviews see [1–6]).
Though their precise mechanism of action is not fully under-
stood, it is widely accepted that the target membrane is the
scene of action, without the exploitation of a specific receptor
[7]. This mechanism differentiates them from classical anti-
biotics and is presumably themain reason for the insignificant
development of microbial resistance against these ‘‘new0005-2736/03/$ - see front matter D 2003 Elsevier Science B.V. All rights reserv
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synthetic analogs thereof have emerged as compounds with
potentially significant therapeutical applications against
human pathogens [9–11].
Antimicrobial peptides are typically small (15–50 amino
acid residues) but have a diverse fold, such as a-helices, h-
sheets and cyclic structures. However, they share an overall
amphipathicity and a positive net charge, which are thought
to be prerequisites for the interaction with the negatively
chargedmembranes of bacteria [12,13]. Among the hundreds
of natural peptides isolated so far (seehttp://www.bbcm.
univ.trieste.it/~tossi/pag1.htm), mammalian defensins [14],
magainins of amphibia [15] and the insect cecropins [16] are
the most prominent representatives. Different models for the
peptide/membrane interaction have been suggested in the
literature: For lower peptide/lipid ratios it has been shown
that magainins and cecropin A are associated with the lipid
headgroups, oriented in parallel to the membrane [17,18], and
thus cover the membrane like a carpet (carpet model [19]).
However, at a distinct peptide/lipid ratio, some peptides seem
to penetrate the bilayer and are then oriented perpendicular toed.
Fig. 1. Structure model of the peptide NK-2. The darkened positively
charged lysine and arginine residues illustrate the segregation of hydrophilic
and hydrophobic residues. The position of the phe/trp exchange in peptide
trpNK-2 is indicated. The structure shown was extracted from the NMR
structure of NK-lysin (residues 39–65) deposited at the PDB (1NKL).
Please note that the sequence of the peptide NK-2 differs from NK-lysin in
three positions (see also Table 1). The a-helical content of the peptide NK-2
was verified by CD spectroscopy [26] and FTIR spectroscopy (this study).
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peptide results in the formation of a toroidal-like pore, where
the peptide is still located at the lipid headgroups, which are
now lining, together with the peptides, the inside of the pore
(toroidal or wormhole model [21,22]). Besides these very
similar carpet-like models, also the formation of distinct
pores has been observed in the case of some peptides
(barrel-stave model [23]). Even intracellular targets have
been identified, if the peptides are able to surmount the
cytoplasmic membrane [7,24].
We have constructed a synthetic short version of NK-
lysin, a cytolytic and antimicrobial polypeptide of porcine
cytotoxic lymphocytes [25], which represents the cationic
core region of this potent effector molecule [26]. NK-lysin
belongs to the saposin-like proteins (SAPLIPs), a family of
8–9 kDa proteins, structurally conserved, but functionally
diverse [27], i.e they share a common a-helical fold with a
conserved half-cysteine pattern [28–30]. Besides the name-
giving saposins and other related proteins, a particular group
of cytotoxic and antibacterial effector molecules of profes-
sional killer cells belongs to that family: Amoebapores,
isolated from the pathogenic amoeba Entamoeba histolytica
[31], Granulysin from human T-cells [32], and the afore-
mentioned NK-lysin [25]. These proteins are stored in
respective cellular cytotoxic granules and secreted upon
contact with a victim cell. In a previous study, we identified
the helical core region of the Amoebapore isoform A (H3,
residues 40–65) as mediator of its antibacterial and cyto-
toxic activities [33]. Using a set of synthetic peptides, we
further improved the activity and also the selectivity of
peptide H3 [34]. Furthermore, we were prompted, by the
striking homology of Amoebapores with NK-lysin [35], to
construct an H3-like peptide also on the basis of the NK-
lysin sequence. Interestingly, this synthetic 27-residue pep-
tide and shortened analog of NK-lysin, termed NK-2,
displayed potent activity against clinical isolates of Candida
albicans, bacteria [26], and also against the protozoan
parasite Trypanosoma cruzi [36], but was of low toxicity
to human cells [26, 36]. We showed by circular dichroism
that NK-2 has a random coiled conformation in solution, but
adopts an amphipathic a-helical structure in hydrophobic
environment [26]. The NK-2 corresponding region of the
NK-lysin 3D-structure, extracted from the protein data bank
(1NKL), revealed a helix–hinge–helix fold of the peptide
(Fig. 1), resembling the structure of cecropin A [37].
Here, we investigated the molecular basis for the selec-
tivity of the synthetic peptide NK-2 utilizing model systems
mimicking the eukaryotic and prokaryotic cytoplasmic
membranes. The phospholipid compositions of these mem-
branes differ markedly. The architecture of the human
erythrocyte cytoplasmic membrane is asymmetric with the
inner leaflet predominantly consisting of the amino phos-
pholipids phosphatidylethanolamine (PE) and small amounts
of negatively charged phosphatidylserine, and the outer
leaflet lacking negatively charged phospholipids but consist-
ing of the choline phospholipids phosphatidylcholine (PC)and sphingomyelin ([38] and references therein). In contrast,
the cytoplasmic membrane of bacteria is essentially a mix-
ture of PE and negatively charged phosphatidylglycerol (PG)
and cardiolipin (between 20% and 100% of total plasma
membrane phospholipids [38]). The situation is even more
complex due to the existence of the Gram-negative outer
membrane, whose outer leaflet is formed nearly exclusively
of lipopolysaccharides. Here, as a first approximation to the
biological system, we used the zwitterionic phospholipid PC
to mimic the human erythrocyte membrane, and a mixture of
zwitterionic PE and negatively charged PG for the plasma
membrane mimetic of Gram-negative bacteria.
The results we present will show clearly that the peptide
NK-2 specifically interacts with the constituents of the
bacterial cytoplasmic membrane but not with the ones of
the human erythrocyte membrane; negative charges promote
this interaction but are not necessary. To allow comparison
with other investigations, we frequently used bee venom
melittin as a control peptide.2. Materials and methods
2.1. Materials
Phospholipids (2-oleoyl-1-palmitoyl-sn-glycero-3-phos-
phocholine, POPC; 2-oleoyl-1-palmitoyl-sn-glycero-3-
phosphoethanolamine, POPE; 2-oleoyl-1-palmitoyl-sn-glyc-
ero-3-phospho-rac-(1-glycerol), POPG), and agarose (low
electroendosmosis type) were purchased from Sigma (Dei-
senhofen, Germany). Trypticase soy broth was from Gibco
(Karlsruhe, Germany). All other chemicals were of analyt-
ical grade from Merck (Darmstadt, Germany).
2.2. Peptides and peptide analysis
Melittin (Apis mellifera) was purchased as synthetic
peptide from Sigma in HPLC-grade and used without
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WITA GmbH (Berlin, Germany) in a purity grade >95%.
Their homogeneity was confirmed by analytical RP-HPLC
(Lichrospher 100 RP 18, 5-Am column, Merck), MALDI-
TOF (Bruker Daltonik GmbH, both performed by the
manufacturer), and N-terminal Edman degradation (Procise
Protein Sequencing System, Applied Biosystems, Ger-
many). The peptides were synthesized with an amidated C
terminus. Mean hydrophobicity and mean hydrophobic
moments of the entire peptides were calculated using the
Eisenberg consensus scale for hydrophobicity [39]. The
existence of a free, non-disulfide bridged, sole cysteine
residue in the peptides, under the experimental conditions,
was confirmed by reactivity to the Ellman reagent [40] and
by MALDI-TOF (BIFLEX, Bruker, Karlsruhe, Germany,
performed by N. Nagorny, Institute of Organic Chemistry,
University of Hamburg).
2.3. Fourier-transformed infrared spectroscopy (FTIR)
The FTIR measurements were performed on an Equinox-
55 spectrometer (Bruker) in connection with an AquaSpec
flow cell (micro-biolytics GmbH, Freiburg, Germany) at 27
jC. Peptides were applied to repeated cycles of solubiliza-
tion in 10 mM HCl, liquid nitrogen, and lyophilization to
remove any trapped TFA, which would interfere with the
FTIR measurements, and finally dissolved in H2O or D2O (5
mM). Interferograms (50) were accumulated, apodized,
Fourier-transformed and converted to absorbance spectra.
The secondary structure was determined by analyzing the
amide I-vibration (predominantly CMO stretching vibra-
tion). For this two different methods were applied: (i) Curve
fitting was done in the spectral range 1700–1600 cm 1
using a modified version of the CURFIT program obtained
by D. Moffat, NRC, Ottawa, Canada. The bandshapes of the
single components are superpositions of Gaussian and
Lorentzian. Best fits were obtained by assuming a Gauss
fraction of 0.55–0.60. The precision of the curve fit
procedure is approximately 3%; and (ii) a calibration was
performed in the spectral region 1800–1275 cm 1 using the
alpha_helix.q2 method and the corresponding protein spec-
tra library of the OPUS/QUANT software package (Bruker).
2.4. Assay for antibacterial activity
Antibacterial activity was determined by a radial diffu-
sion assay [41]. The two different layers of the assay both
contained 1% agarose, buffered with 10 mM sodium phos-
phate, pH 7.4, and were autoclaved before seeding of the
bacteria. The underlayer agar was supplemented with 0.03%
trypticase soy broth, 0.02% Tween 20, and contained 105
cfu/ml of log-phase E. coli (ATCC 23716). The overlayer
agar was supplemented with 6% trypticase soy broth.
Underlayer agar (10 ml) was filled in a squared petri dish
(12 12 cm); holes with 3.5-mm diameter were punched
into the solidified agarose which were filled with 5 Al of thesample. After an incubation period of 3 h at 37 jC, the plate
was covered with 10-ml overlayer agar. The plates were
incubated overnight at 37 jC. Inhibition zones were ex-
pressed in units, with one unit defined as diameter of
clearance in millimeter (minus 3.5 mm of the sample
containing hole) multiplied by 10.
2.5. Assay for hemolytic activity
Freshly collected human erythrocytes were washed
with phosphate-buffered saline (10 mM sodium phos-
phate, 2 mM potassium chloride, 138 mM sodium chlor-
ide, pH 7.4), and resuspended in MES-buffered saline (20
mM MES, 140 mM sodium chloride, pH 5.5, 5 108/
ml). Subsequently, 20 Al of this erythrocyte suspension
was incubated with 80 Al of peptide solution in the same
buffer for 30 min at 37 jC. For controls, erythrocytes
were incubated with distilled water (maximal lysis) and
buffer alone (spontaneous lysis). Lysis was determined by
measuring the concentration of released hemoglobin at
412 nm. Percent lysis was defined as (experimental
lysis spontaneous lysis)/(maximal lysis spontaneous
lysis) 100.
2.6. Preparation of lipid vesicles (LUV)
Pure phospholipids or mixtures thereof (2.5 mg) were
dissolved in chloroform/methanol (2:1, by volume), the
solvent was removed by a constant stream of nitrogen,
and the resulting lipid film was dried under vacuum over-
night. Subsequently, the lipid film was hydrated in buffer
(10 mM sodium phosphate, pH 7.4) to reach a final
concentration of 2 mM phospholipid. The suspension was
subjected to four freeze-and-thaw cycles with liquid nitro-
gen and a waterbath of 37 jC, and passed through a 100-nm
membrane for 17 times using a liposome extruder (Lip-
osoFast, Avestin Inc., Ottawa, Canada).
2.7. Liposome lysis assay
LUVs were prepared as described above, with the varia-
tion of the lipid films being hydrated in buffer (10 mM
HEPES, 1 mM EDTA, pH 7.4) containing 30 mM calcein
(Molecular Probes, Leiden, Netherlands). After extrusion, the
liposomes were passed over a PD-10 column (Amersham
Bioscience, Freiburg, Germany) to remove untrapped cal-
cein. Elution was done with 10mMHEPES, 150mMNaCl, 1
mM EDTA, pH 7.4. Lipid concentration was determined
using a phosphorus assay [42]. Liposomes (2.5 AM of
phospholipids) were treated with various amounts of peptide
at 20 jC and the peptide-induced lysis was monitored fluoro-
metrically by the detection of fluorescent dye release at
excitation and emission wavelengths of 490 and 520 nm,
respectively (Aminco SPF-500). After signals have been
recorded for 10 min (Fexp), complete dye release was
achieved by treatment of liposomes with 0.1% Triton X-
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the time of the experiment (20 min) was less than 2%. Percent
lysis was calculated as (FexpF0)/(F100%F0) 100. F0
was the fluorescence level before the addition of peptide.
2.8. Biosensor measurements
The optical biosensor IAsys (Thermo Labsystems, Cam-
bridge, UK) uses the resonant mirror technique to monitor the
direct molecular interaction of a ligand with a surface in real
time. Binding and dissociation events are seen as increasing
and decreasing shifts in resonance angle given in arc seconds
(arc sec). In our approach, we used a two-well cuvette system
with hydrophobic coated surfaces. Lipid monolayers were
deposited on the surface from chloroform solutions (lipid
concentration 20 mg/ml) using the manufacturer’s protocol.
The deposition was followed by washes of 50% sucrose (w/
v), buffer (10 mM sodium phosphate, 1 mM EDTA, pH 7.4),
100 mM HCl, buffer, 10 mM NaOH, and again buffer. Lipid
deposition and all measurements were done at 28 jC. After
the baseline was stable, the amount of lipid on the surface was
determined and typically was around 1000 arc sec. The
homogeneity of the surface was routinely checked by reso-
nance scans. Only surfaces which give a single peak were
used for the measurements. Peptide was added to give a final
concentration of 1 AM and the increasing signal was moni-
tored over time. Repeated binding experiments were done on
freshly prepared monolayers.
2.9. Intrinsic tryptophan fluorescence measurements
Intrinsic tryptophan fluorescence was measured using an
Aminco SPF-500 spectrofluorometer. Peptides (5 AM) were
dissolved in buffer (10 mM sodium phosphate, pH 7.4).
Liposomes (LUV) were added to a final molar ratio as
indicated. The samples (500 Al) were equilibrated at 27 jC
for 5 min. Excitation was done at 280 nm and emission was
recorded from 300 to 500 nm. Both slits were set to 4 nm. The
spectra of all peptide/liposome mixtures were corrected by
subtracting the emission spectra of a liposome suspension of
the respective concentration. Data were fitted to a log-normal
distribution (proFit 5.1.2, Quantum Soft, Zu¨rich, Switzer-
land) and kmax was obtained from the fitted curves. As a
control for artificial wavelength shifts due to scattering effect
of the liposome suspension, we recorded spectra of free Trp (5
AM). Only in the presence of a 300-fold molar excess of
phospholipids a minimal artificial blue-shift was observed
(0.5 to 1.7 nm).
Fig. 2. Secondary structure analysis. Peptide secondary structure was
determined by FTIR spectroscopy by analyzing the amide I-vibration. (A)
Spectral range of amide I and II (CMO) stretching vibrations of NK-2 (5
mM) in H2O (dashed line) and D2O (solid line). (B) Band shape analysis of
amide I stretching vibration (open circles) of NK-2 (5 mM) in D2O. The
curve fit (solid line) and the single component bands (dashed lines) are
shown. The major single component band is centered around 1648 cm 1
and can be assigned to an a-helical secondary structure. (C) Amide I
stretching vibration of NK-2 (solid line) and trpNK-2 (dashed line)
solubilized in H2O (5 mM).3. Results
3.1. Peptide construction and structural analysis
The sequence of the antibacterial and candidacidal pep-
tide NK-2 was derived from the core region (residues 39–65) of NK-lysin. It spans its third and fourth a-helical
domain including the (mostly positively charged) adjacent
amino acid residues. The solution structure of the peptide
was determined in H2O and D2O by FTIR spectroscopy
(Fig. 2A). Since random coil contribution could superim-
pose to the helical contribution in H2O, we performed
secondary structure analysis in D2O (Fig. 2B). Dissection
of the amide I-vibration band of NK-2 into single compo-
nent bands revealed a strong band centered around 1648
cm 1 and minor bands at 1669, 1637 and 1607 cm 1,
indicating a high portion of a-helical secondary structure
(48.6%). A very similar amount of a-helical content
(51.0%) was obtained by applying a quantitative method
(OPUS/QUANT) based on the comparison of a protein
spectra library of known structures. For the analysis of its
membrane interaction by fluorescence spectroscopy, we
Table 1
Peptide used in this study
Residues identical to the NK-2 sequence are indicated by a hyphen. Net charges of the peptides were calculated by counting the amino terminus, arginine and
lysine as positive charges, and aspartic acid residues as negative charges (there is no glutamic acid residue in any peptide); H, mean hydrophobicity; hli, mean
hydrophobic moment; *, partial sequence of NK-lysin (residues 39–65) [25].
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NK-2; i.e. we substituted a phenylalanine by a tryptophan
residue (trpNK-2). This exchange neither influenced the
hydrophobic properties of the peptide (Table 1) nor its
secondary structure, indicated by an identical shape of the
amide I-vibration band determined by FTIR-spectroscopy
(Fig. 2C). Though both peptides contain a sole cysteine
residue, intermolecular disulfide formation was not ob-
served under the experimental conditions (not shown).
3.2. Biological activity
The two synthetic peptides, NK-2 and trpNK-2, were
nearly indistinguishable concerning their antibacterial and
hemolytic activities (Fig. 3). Both were active against E. coli
at a similar concentration as melittin, a highly antibacterialFig. 3. Antibacterial and hemolytic activities of synthetic peptides. (A)
Antibacterial activity was determined in a radial diffusion assay. Here, an
inhibition zone of 0.1 mm is defined as one unit. (B) Hemolytic activity was
determined by measuring the release of hemoglobin after incubation of the
peptides with human erythrocytes for 30 min at 37 jC. Values were
determined in duplicates at least in two independent experiments.and hemolytic peptide from bee venom. However, in con-
trast to melittin, the NK-2 peptides were not hemolytic to
human erythrocytes.
3.3. Membrane permeabilization
Release of the fluorescent dye calcein from LUVs of a
defined lipid composition after the addition of peptide was
monitored over the time. We used liposomes composed of
zwitterionic PC and of a mixture of zwitterionic PE and
negatively charged PG to mimic the outer layer of human
erythrocytes and the bacterial cytoplasmic membrane,
respectively. Whereas NK-2 was very effective to evoke
calcein release from the negatively charged liposomes (PE/
PG), virtually no release was observed with LUVs com-
posed of pure PC (Fig. 4). In contrast, bee venom melittinFig. 4. NK-2 induced liposome lysis. Peptide induced lysis of calcein
containing LUVs made of (A) PC and of (B) a molar 80:20 mixture of PE/
PG monitored fluorometrically by the detection of dye release at room
temperature. Percent leakage was calculated then as described in Material
and methods and presented here dependent on the lipid/peptide molar ratio.
For comparison, melittin was used at the same concentrations.
Fig. 6. Intrinsic tryptophan fluorescence. After excitation at 280 nm,
fluorescence emission spectra were recorded in the absence of lipids (A) for
trpNK-2, melittin (Mel), and L-tryptophan (Trp). (B) Emission spectra of
trpNK-2 in the absence (1) and presence of LUVs, at a 30-fold molar excess
of phospholipids consisting of PC (2), PE (3) and a molar 80:20 mixture of
PE/PG (4).
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and evokes liposome leakage irrespective of its lipid com-
position (Fig. 4).
3.4. Membrane binding kinetics
In order to discriminate between membrane association,
insertion and lysis, we first analyzed the binding kinetics of
the peptide NK-2 on lipid monolayers utilizing a biosensor
system. Monolayers were generated on a hydrophobic sur-
face cuvette, NK-2 was added and the amount of bound
peptide was monitored in real time by the resonant mirror
technique. Monolayers consist of pure PC or PE and a 80:20
molar mixture of PE/PG. An increasing signal, correspond-
ing to the amount of bound peptide, was seen with PE/PG,
but also with pure PE monolayers. Virtually no interaction
was observed with pure PC (Fig. 5). A critical step in
biosensor experiments is the regeneration of the used sur-
face, i.e., in our case the removal of the peptide from the
lipid monolayer. We tried to do this by treatment with
multiple cycles of high salt, NaOH and HCl. In the case
of NK-2 bound to the PE/PG monolayer, this procedure did
not result in a decrease of the binding signal, indicating that
the peptide could not be removed. However, NK-2 bound to
PE was detached from the monolayer by three or four
washing cycles with HCl and buffer, as evidenced by a
signal drop back to the membrane level (not shown).
3.5. Membrane binding mode
Fluorescence emission spectra were recorded, after exci-
tation at 280 nm, for trpNK-2, melittin and L-tryptophan
(Trp) as a reference. The wavelengths of the emission
maxima (kmax) of trpNK-2 and melittin in buffer alone were
345.4 and 348.4 nm, respectively (n = 19), and very similar
to kmax of free Trp (350.0 nm, n = 3), thus indicating full
solvent exposure of the tryptophan side chains in trpNK-2
and melittin (Fig. 6A). Lipid vesicles were added then in
great molar excess (30- to 300-fold) to guarantee fullFig. 5. Membrane binding kinetics of NK-2. The peptide NK-2 was added
to a biosensor surface covered with monolayers of PC, PE or a molar 80:20
mixture of PE/PG. The increasing binding signal (Response, arc sec) was
recorded over time.saturation of peptide with lipids. The phospholipid compo-
sition of the vesicles had a strong influence on the emission
spectra of trpNK-2 (Fig. 6B). At a 30-fold molar excess of
phospholipids: (i) a strong blue-shift (kmax = 328.1 nm),
indicating a membrane-buried tryptophan, was observed in
the presence of negatively charged LUVs (PE/PG); and (ii) a
slight shifting (kmax = 338.8 nm), indicating a semi-exposed
trp side chain, was observed in the presence of pure
zwitterionic PE; whereas (iii) virtually no shift was seen
with LUVs of pure zwitterionic PC up to a 300-fold molar
excess (Fig. 6B). For comparison, the trp-fluorescence
emission of melittin also was strongly affected after addition
of LUV, but was more or less independent of the liposome
phospholipid composition (not shown).4. Discussion
We have shown previously that the peptide NK-2 is very
effective against several strains of bacteria and Candida
with inhibitory concentrations of less than 1 AM, but is
virtually inactive against human erythrocytes and keratino-
cytes [26]. The main site of action is the target cell
membrane as demonstrated by liposome lysis experiments
[26]. Therefore, it seems reasonable to suppose that the
H. Schro¨der-Borm et al. / Biochimica et Biophysica Acta 1612 (2003) 164–171170peptide’s selective membranolytic activity is based on
differences in target cell membrane composition. To eluci-
date this selectivity, we used model biomembranes of a
distinct phospholipid composition mimicking mammalian
or bacterial cytoplasmic membranes. In this paper, we
focussed our investigations on NK-2 interactions with the
different phospholipid headgroups, albeit it has been shown
that interaction of peptides can also be affected by the alkyl
chain composition. To avoid this problem, we used identical
alkyl chains (PO= palmitoyl, oleoyl) for all phospholipids
throughout this work. Our experimental models include dye
release from unilamellar lipid vesicles (LUV), peptide bind-
ing to lipid monolayers on a biosensor surface, and the
change in fluorescence emission of an intrinsic tryptophan
residue after association to LUV.
The results obtained by the three different methods
concur in their major statement, and are in a good
correlation to the antibacterial, hemolytic, cytotoxic and
candidacidal data ascertained for NK-2 so far (Ref. [26]
and this study). Obviously, NK-2 is able to discriminate
between different cell types based on different composi-
tions of their respective lipid matrix. It seems clear that a
strong electrostatic interaction of the cationic peptide and a
negatively charged membrane surface promotes the pep-
tide/membrane association. We already have found such a
preference for the Amoebapores [43,44] and derivatives
thereof [33,34], and this has also been reported for the
cecropins [13], defensins [12,45] and various other pep-
tides. However, our biosensor experiments also revealed a
binding capability of NK-2 for the zwitterionic PE surface
(the amount of bound peptide reaches approximately 1/3
the level of the negatively charged PE/PG surface),
whereas virtually no NK-2 binding was observed to the
PC monolayer. This PC vs. PE discrimination was surpris-
ing, but was verified subsequently by following the
changes of the intrinsic tryptophan fluorescence during
peptide/liposome interaction, and raises the following
question: How does NK-2 distinguish between the identi-
cal charged and chemically very similar structured PC and
PE headgroups? One important difference between PC and
PE is their head group geometry [46]. Whereas both
phospholipids form lamellar lipid phases at physiological
temperatures, the cone-shaped PE causes a negative mem-
brane curvature and thus promotes the formation of non-
lamellar, inverted lipid phases at higher temperatures. It is
suggestive to think that NK-2 binding would promote this
curvature strain, which subsequently leads to the collapse
of the bacterial cytoplasmic membrane. For other lytic
peptides, a stabilizing (magainin 2 [47]) as well as a
destabilizing (gramicidin S [48]) influence on the lamellar
phase of PE has been observed. However, these differences
in lipid phase behaviour might explain the differences in
NK-2-induced membrane lysis, for instance in the anti-
bacterial vs. hemolytic assay, albeit they do not explain the
differences in NK-2 attachment to the model membranes.
Possibly, the voluminous trimethylamine umbrella of thecholine group shields the negative charge of the phosphate
group more efficiently than does the amine group of the
ethanolamine moiety. This could result in local negative
charges on the PE membrane which facilitates binding of
the positively charged peptide.
The fluorescence of the tryptophan side chain is sensitive
to the polarity of the environment and thus is a powerful
tool to study the microenvironment of amino acid residues
in proteins (see Ref. [49] and references therein). Weak and
strong wavelength shifts of the Trp emission maximum
allow to distinguish between semi exposed and fully mem-
brane buried Trp side chains, respectively [50]. The peptide
NK-2 lacks a tryptophan residue; however, we introduced a
sole Trp residue as an intrinsic fluorescence probe by
substituting the phenylalanine residue in position 14 (see
also Fig. 1 and Table 1). From a hydrophobic point of view,
this phe/trp substitution is rather conservative, and conse-
quently no dramatic changes in activity were found by our
biological assays. Analysis of the secondary structure of
NK-2 and the tryptophan variant trpNK-2 by FTIR-spectro-
scopy revealed a nearly identical amide I vibration band,
indicating, first, that no structural changes occur due to the
amino acid exchange, and second, that both peptides have
an high content of a-helical structure in water (i.e. in a
hydrophilic environment). This finding is somewhat differ-
ing to CD-spectroscopy data obtained earlier, where we
found an a-helical structure for NK-2 only in the presence
of trifluoroethanol (hydrophobic environment) [26]. How-
ever, the peptide concentration was approximately 15 times
lower in the CD experiment compared to the FTIR measure-
ments, which might influence the formation of a defined
secondary structure [51]. The fluorescence data obtained
suggest a superficial membrane interaction for trpNK-2 with
PE liposomes (semi-exposed trp), but a strong hydrophobic
environment for the trp side chain (i.e. a membrane-buried
trp) if negatively charged phospholipids (PG) are present. A
congruent interpretation can be drawn from the biosensor
data: on one hand, NK-2 could be removed from the PE
monolayer, i.e. a superficial attachment of the peptide; on
the other hand, regeneration failed for the PE/PG mono-
layer, the peptide must stick strongly on, or penetrate into
the lipid layer.
We conclude, and it is likely, that similar factors, as
found for its shortened analog NK-2, also determine the
membrane selectivity of NK-lysin; on the molecular level,
the target cell specificity of NK-2 only partly is based on an
electrostatic interaction between the positively charged side
chains of the peptide and the negatively charged membrane,
which have been made responsible for the action of many
antibacterial peptides on the bacterial cytoplasmic mem-
brane [9,52]. Anionic charges promote membrane binding
of the peptide and are necessary to manifest a strong
interaction/penetration of NK-2; this could also hold true
for zwitterionic PE as discussed above. On the other hand,
the postulated wedge geometry of NK-2 (Fig. 1), in combi-
nation with the particular segregation of cationic and hydro-
H. Schro¨der-Borm et al. / Biochimica et Biophysica Acta 1612 (2003) 164–171 171phobic amino acid residues on the outside and inside of the
alpha-helix, respectively, would allow to enhance the intrin-
sic negative curvature strain of a PE lamellar phase. Other
membrane components, particularly the presence of choles-
terol exclusively in the eukaryotic membrane, may further
improve the peptide target selectivity as it has been reported
for magainin 2 [53]. The discrimination between PE and PC,
the major (‘uncharged’) phospholipid constituents of bacte-
rial and human plasma membranes, respectively, is an
inherent, interesting feature of NK-2 and needs further
investigations.Acknowledgements
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